USAC
Bullish signal
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Supports a bullish reading. Open-market purchases outweigh sales
- Congress Supports a bullish reading. 1 purchase disclosure year to date
- Financial indicators Supports a bullish reading. Current ratio 1.27 · operating margin 32%
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Timing Supports a bullish reading. Interesting trend — weekly bias up
ACHAT TOTAL: 10000 titres (~262200 USD)
- Insiders
- Whitehurst Bradford D.
- Total bought
-
$262,200
Avg buy (VWAP, 90d window) $26.22 vs last close $25.83 (-1.5%)
- Total sold
-
—
Avg sell (VWAP, 90d window) —
- Last activity
- 2026-08-21
- Liquidity
- Thin $12,500,445/day · 20d vol
- Last synced
-
2026-09-23 21:11:09
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-08-21 | Whitehurst Bradford D. | Buy | 6,000 | $26.10 | $156,600 | Form 4 |
| 2026-08-20 | Whitehurst Bradford D. | Buy | 4,000 | $26.40 | $105,600 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Bullish signalScored 2026-09-13
USAC presents a moderate opportunity driven by improving operational fundamentals and a meaningful insider buy following a Q2 earnings beat, suggesting insider confidence in near-term momentum.
The first sentence of the analysis written for USAC on 2026-09-13 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 38.5% | 67.5% | 66.8% | 67.3% | 69.8% | |
| Ebit Margin | 30.4% | 31.9% | 28.8% | 24.5% | 22.7% | |
| Ebitda Margin | 59.0% | 59.7% | 57.9% | 58.0% | 60.4% | |
| Operating Profit Margin | 31.9% | 31.0% | 27.4% | 24.0% | 22.3% | |
| Pretax Profit Margin | 11.6% | 10.7% | 8.2% | 4.4% | 1.8% | |
| Continuous Operations Profit Margin | 11.2% | 10.5% | 8.1% | 4.3% | 1.6% | |
| Net Profit Margin | 11.2% | 10.5% | 8.1% | 4.3% | 1.6% | |
| Bottom Line Profit Margin | 10.3% | 8.6% | 2.4% | -2.6% | -6.1% | |
| Current Ratio | 1.266 | 1.232 | 1.208 | 1.074 | 1.092 | |
| Quick Ratio | 0.546 | 0.530 | 0.596 | 0.534 | 0.635 | |
| Solvency Ratio | 0.145 | 0.134 | 0.123 | 0.116 | 0.114 | |
| Cash Ratio | 0.046 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Price To Earnings Ratio | 27.059 | 32.722 | 108.714 | -102.789 | -43.625 | |
| Price To Earnings Growth Ratio | 1.499 | 0.135 | -0.516 | 1.958 | 0.467 | |
| Forward Price To Earnings Growth Ratio | 1.499 | 0.135 | -0.516 | 1.958 | 0.467 | |
| Price To Earnings Diluted Ratio | 27.059 | 32.722 | 114.150 | -102.789 | -43.625 | |
| Price To Earnings Diluted Growth Ratio | 1.499 | 0.126 | -0.556 | 1.958 | 0.467 | |
| Price To Book Ratio | -24.687 | 96.241 | 12.302 | 5.290 | 2.928 | |
| Price To Sales Ratio | 2.783 | 2.811 | 2.661 | 2.710 | 2.677 | |
| Price To Free Cash Flow Ratio | 10.027 | 19.574 | 67.494 | 15.112 | 7.692 | |
| Price To Operating Cash Flow Ratio | 7.045 | 7.826 | 8.282 | 7.328 | 6.382 | |
| Debt To Assets Ratio | 0.974 | 0.918 | 0.859 | 0.798 | 0.721 | |
| Debt To Equity Ratio | -22.674 | 90.776 | 12.843 | 5.892 | 3.452 | |
| Debt To Capital Ratio | 1.046 | 0.989 | 0.928 | 0.855 | 0.775 | |
| Long Term Debt To Capital Ratio | 1.046 | 0.989 | 0.927 | 0.854 | 0.773 | |
| Financial Leverage Ratio | -23.288 | 98.912 | 14.951 | 7.384 | 4.785 | |
| Working Capital Turnover Ratio | 21.242 | 22.830 | 32.716 | 46.778 | 27.138 | |
| Operating Cash Flow Ratio | 2.109 | 1.790 | 1.450 | 1.501 | 1.415 | |
| Operating Cash Flow Sales Ratio | 0.395 | 0.359 | 0.321 | 0.370 | 0.420 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.703 | 0.400 | 0.123 | 0.485 | 0.830 | |
| Debt Service Coverage Ratio | 3.036 | 2.922 | 2.873 | 2.870 | 2.937 | |
| Interest Coverage Ratio | 1.698 | 1.522 | 1.365 | 1.226 | 1.085 | |
| Short Term Operating Cash Flow Coverage Ratio | 81.814 | 0.000 | 0.000 | 63.327 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.155 | 0.135 | 0.116 | 0.123 | 0.133 | |
| Capital Expenditure Coverage Ratio | 3.362 | 1.666 | 1.140 | 1.941 | 5.871 | |
| Dividend Paid And Capex Coverage Ratio | 1.026 | 0.726 | 0.548 | 0.667 | 0.884 | |
| Dividend Payout Ratio | 2.397 | 2.664 | 3.776 | 8.450 | 24.816 | |
| Enterprise Value Multiple | 9.041 | 9.148 | 9.401 | 9.870 | 9.656 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 38.5% | ▼-29.0% | ▼-23.5% |
| Ebit Margin | 30.4% | ▼-1.4% | ▲2.8% |
| Ebitda Margin | 59.0% | ▼-0.8% | ▼-0.0% |
| Operating Profit Margin | 31.9% | ▲0.9% | ▲4.6% |
| Pretax Profit Margin | 11.6% | ▲0.9% | ▲4.3% |
| Continuous Operations Profit Margin | 11.2% | ▲0.7% | ▲4.0% |
| Net Profit Margin | 11.2% | ▲0.7% | ▲4.0% |
| Bottom Line Profit Margin | 10.3% | ▲1.7% | ▲7.8% |
| Current Ratio | 1.266 | ▲0.033 | ▲0.091 |
| Quick Ratio | 0.546 | ▲0.016 | ▼-0.022 |
| Solvency Ratio | 0.145 | ▲0.011 | ▲0.019 |
| Cash Ratio | 0.046 | ▲0.046 | ▲0.037 |
| Price To Earnings Ratio | 27.059 | ▼-5.663 | ▲22.643 |
| Price To Earnings Growth Ratio | 1.499 | ▲1.364 | ▲0.790 |
| Forward Price To Earnings Growth Ratio | 1.499 | ▲1.364 | ▲0.790 |
| Price To Earnings Diluted Ratio | 27.059 | ▼-5.663 | ▲21.555 |
| Price To Earnings Diluted Growth Ratio | 1.499 | ▲1.373 | ▲0.800 |
| Price To Book Ratio | -24.688 | ▼-120.928 | ▼-43.102 |
| Price To Sales Ratio | 2.783 | ▼-0.028 | ▲0.054 |
| Price To Free Cash Flow Ratio | 10.027 | ▼-9.546 | ▼-13.953 |
| Price To Operating Cash Flow Ratio | 7.045 | ▼-0.782 | ▼-0.328 |
| Debt To Assets Ratio | 0.974 | ▲0.056 | ▲0.120 |
| Debt To Equity Ratio | -22.674 | ▼-113.450 | ▼-40.732 |
| Debt To Capital Ratio | 1.046 | ▲0.057 | ▲0.128 |
| Long Term Debt To Capital Ratio | 1.046 | ▲0.057 | ▲0.129 |
| Financial Leverage Ratio | -23.288 | ▼-122.200 | ▼-43.837 |
| Working Capital Turnover Ratio | 21.242 | ▼-1.589 | ▼-8.899 |
| Operating Cash Flow Ratio | 2.109 | ▲0.319 | ▲0.456 |
| Operating Cash Flow Sales Ratio | 0.395 | ▲0.036 | ▲0.022 |
| Free Cash Flow Operating Cash Flow Ratio | 0.703 | ▲0.303 | ▲0.195 |
| Debt Service Coverage Ratio | 3.036 | ▲0.114 | ▲0.108 |
| Interest Coverage Ratio | 1.698 | ▲0.176 | ▲0.318 |
| Short Term Operating Cash Flow Coverage Ratio | 81.814 | ▲81.814 | ▲52.786 |
| Operating Cash Flow Coverage Ratio | 0.155 | ▲0.019 | ▲0.022 |
| Capital Expenditure Coverage Ratio | 3.362 | ▲1.696 | ▲0.566 |
| Dividend Paid And Capex Coverage Ratio | 1.026 | ▲0.300 | ▲0.256 |
| Dividend Payout Ratio | 2.397 | ▼-0.266 | ▼-6.023 |
| Enterprise Value Multiple | 9.041 | ▼-0.107 | ▼-0.382 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $2.78B | $2.67B | $2.25B | $1.91B | $1.69B | |
| Enterprise value | $5.32B | $5.19B | $4.60B | $4.04B | $3.69B | |
| EV / Sales | 5.33x | 5.46x | 5.44x | 5.73x | 5.83x | |
| EV / Op. cash flow | 13.49x | 15.21x | 16.93x | 15.49x | 13.90x | |
| EV / Free cash flow | 19.21x | 38.04x | 137.96x | 31.94x | 16.76x | |
| EV / EBITDA | 9.04x | 9.15x | 9.40x | 9.87x | 9.66x | |
| Net debt / EBITDA | 4.32x | 4.44x | 4.80x | 5.20x | 5.22x | |
| Current ratio | 1.27x | 1.23x | 1.21x | 1.07x | 1.09x | |
| Income quality | 3.54x | 3.43x | 3.98x | 8.60x | 25.82x | |
| Graham number | — | $2 | $5 | $5 | $4 | |
| Graham net-net | -$21 | -$23 | -$25 | -$22 | -$22 | |
| Tax burden | 95.8% | 97.8% | 98.0% | 96.8% | 92.2% | |
| Interest burden | 38.3% | 33.6% | 28.6% | 18.2% | 7.8% | |
| Working capital | $49.7M | $44.3M | $38.9M | $12.8M | $17.3M | |
| Invested capital | $2.41B | $2.55B | $2.54B | $2.48B | $2.56B | |
| Return on assets | 4.2% | 3.6% | 2.5% | 1.1% | 0.4% | |
| Operating ROA | 11.9% | 10.7% | 8.6% | 6.2% | 4.9% | |
| Return on tangible assets | 4.6% | 3.9% | 2.7% | 1.3% | 0.4% | |
| Return on equity | -98.9% | 358.7% | 37.3% | 8.4% | 1.8% | |
| Return on invested capital | 12.5% | 11.3% | 8.9% | 6.6% | 5.0% | |
| Return on capital employed | 13.1% | 11.5% | 9.1% | 6.8% | 5.5% | |
| Earnings yield | 4.0% | 3.7% | 3.0% | 1.6% | 0.6% | |
| Free cash flow yield | 10.0% | 5.1% | 1.5% | 6.6% | 13.0% | |
| Capex / Op. cash flow | 29.7% | 60.0% | 87.7% | 51.5% | 17.0% | |
| Capex / Depreciation | 41.2% | 77.4% | 96.9% | 56.7% | 18.9% | |
| Capex / Sales | 11.8% | 21.6% | 28.2% | 19.0% | 7.1% | |
| SG&A / Sales | 6.6% | 0.0% | 0.0% | 0.0% | 0.0% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.4% | 1.7% | 2.6% | 2.3% | 2.5% | |
| Intangibles / Total assets | 7.1% | 7.9% | 9.0% | 10.3% | 11.0% | |
| Days sales outstanding | 30d | 34d | 41d | 43d | 39d | |
| Days payables outstanding | 17d | 32d | 52d | 56d | 43d | |
| Operating cycle | 110d | 193d | 190d | 192d | 204d | |
| Cash conversion cycle | 93d | 160d | 139d | 136d | 160d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+4.0%EV / Sales ▼-2.4%EV / EBITDA ▼-1.2%EV / Op. cash flow ▼-1.716Earnings yield ▲+0.003
Profitability
Return on equity ▼-4.577Return on assets ▲+0.006Return on invested capital ▲+0.013Return on capital employed ▲+0.016Operating ROA ▲+0.011Income quality ▲+0.114Tax burden ▼-0.020
Efficiency
Days sales outstanding ▼-4.061Days payables outstanding ▼-15.485Operating cycle ▼-82.370Cash conversion cycle ▼-66.886Capex / Sales ▼-0.098R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.033Net debt / EBITDA ▼-0.119Working capital ▲+5340000.000Invested capital ▼-135412000.000Intangibles / Total assets ▼-0.007
Change over 5 years
Valuation
Market cap ▲+64.0%EV / Sales ▼-8.6%EV / EBITDA ▼-6.4%EV / Op. cash flow ▼-0.410Earnings yield ▲+0.034
Profitability
Return on equity ▼-1.007Return on assets ▲+0.039Return on invested capital ▲+0.075Return on capital employed ▲+0.076Operating ROA ▲+0.069Income quality ▼-22.280Tax burden ▲+0.036
Efficiency
Days sales outstanding ▼-9.218Days payables outstanding ▼-26.389Operating cycle ▼-93.386Cash conversion cycle ▼-66.997Capex / Sales ▲+0.046R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.173Net debt / EBITDA ▼-0.903Working capital ▲+32316000.000Invested capital ▼-151371000.000Intangibles / Total assets ▼-0.039
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2022-04-18 | Mark Dr Green | Sale (Full) | $500,001 - $1,000,000 |
| 2022-04-14 | Mark Dr Green | Sale (Full) | $100,001 - $250,000 |
| 2022-01-06 | Mark Dr Green | Purchase | $100,001 - $250,000 |
| 2021-12-29 | Mark Dr Green | Purchase | $250,001 - $500,000 |
| 2021-11-08 | Mark Dr Green | Sale (Full) | $250,001 - $500,000 |
| 2021-10-15 | Mark Dr Green | Purchase | $250,001 - $500,000 |
| 2021-10-07 | Mark Dr Green | Purchase | $100,001 - $250,000 |
| 2021-09-01 | Mark Dr Green | Purchase | $100,001 - $250,000 |
| 2021-08-11 | Mark Dr Green | Sale (Full) | $500,001 - $1,000,000 |
| 2021-07-09 | Mark Dr Green | Purchase | $100,001 - $250,000 |
| 2021-05-13 | Mark Dr Green | Purchase | $100,001 - $250,000 |
| 2021-05-12 | Mark Dr Green | Sale (Full) | $100,001 - $250,000 |
| 2021-05-05 | Mark Dr Green | Sale (Full) | $250,001 - $500,000 |
| 2021-04-14 | Mark Dr Green | Purchase | $50,001 - $100,000 |
| 2021-03-08 | Mark Dr Green | Purchase | $1,001 - $15,000 |
| 2021-03-08 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2021-03-04 | Mark Dr Green | Purchase | $50,001 - $100,000 |
| 2021-03-01 | Mark Dr Green | Purchase | $50,001 - $100,000 |
| 2021-02-24 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2021-02-22 | Mark Dr Green | Purchase | $50,001 - $100,000 |
| 2021-02-19 | Mark Dr Green | Purchase | $100,001 - $250,000 |
| 2021-02-18 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2021-02-12 | Mark Dr Green | Purchase | $50,001 - $100,000 |
| 2021-01-19 | Mark Dr Green | Purchase | $100,001 - $250,000 |
| 2021-01-15 | Mark Dr Green | Purchase | $100,001 - $250,000 |
| 2020-12-01 | Mark Dr Green | Purchase | $100,001 - $250,000 |
| 2020-11-18 | Mark Dr Green | Purchase | $100,001 - $250,000 |
| 2020-11-17 | Mark Dr Green | Purchase | $100,001 - $250,000 |
| 2020-11-09 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-10-22 | Mark Dr Green | Purchase | $100,001 - $250,000 |
| 2020-10-16 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-10-05 | Mark Dr Green | Purchase | $50,001 - $100,000 |
| 2020-10-05 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-09-16 | Mark Dr Green | Sale (Full) | $100,001 - $250,000 |
| 2020-09-11 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-08-28 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-08-12 | Mark Dr Green | Purchase | $1,001 - $15,000 |
| 2020-08-11 | Mark Dr Green | Purchase | $1,001 - $15,000 |
| 2020-08-10 | Mark Dr Green | Purchase | $1,001 - $15,000 |
| 2020-08-06 | Mark Dr Green | Purchase | $1,001 - $15,000 |
| 2020-08-04 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-07-08 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-07-07 | Mark Dr Green | Purchase | $50,001 - $100,000 |
| 2020-07-02 | Mark Dr Green | Purchase | $100,001 - $250,000 |
| 2020-06-11 | Mark Dr Green | Purchase | $1,001 - $15,000 |
| 2020-06-10 | Mark Dr Green | Purchase | $15,001 - $50,000 |
| 2020-06-10 | Mark Dr Green | Purchase | $100,001 - $250,000 |
Recent news
- 2026-08-11 USA Compression Q2 Earnings & Revenues Beat Estimates, Rise Y/Y USAC''s Q2 earnings and revenues beat estimates as higher capacity and contract operations drive strong year-over-year growth.
- 2026-08-11 Is USAC Worth Buying for Growth Despite Margin and Leverage Risks? USA Compression''s contracted fleet supports long-term upside, but margin pressure, leverage and a premium valuation leave little room for execution misses.
- 2026-08-10 Interest Rates Could Still Rise in September: 5 High-Yield Passive Income Stocks Will Benefit Surging oil prices, a CPI spike not seen in three years, and Treasury yields at levels last touched in 2007 are forcing a September rate decision that could reshape which stocks lead the market through the rest of 2026.
- 2026-08-09 USA Compression Partners Q2 Earnings Call Highlights USA Compression Partners NYSE: USAC reported higher second-quarter revenue and maintained its full-year financial outlook as the company continued integrating the J-W acquisition, expanded its fleet planning and cited extended equipment lead times and customer demand visibility.
- 2026-08-07 USA Compression (USAC) Reports Q2 Earnings: What Key Metrics Have to Say The headline numbers for USA Compression (USAC) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 2026-08-07 20 Years on Wall Street Taught Me to Buy and Hold 5 High-Yield Energy Giants After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional perspective on dividend stock investing.
- 2026-08-05 4 High-Yield Energy Stocks With 6% and Higher Dividends Are Strong Buys Before September It''s likely a good bet that the Federal Reserve will raise the federal funds rate by 25 basis points (1/4 of 1%) in September.
- 2026-08-05 USA Compression Partners, LP Common Units (USAC) Q2 2026 Earnings Call Transcript USA Compression Partners, LP Common Units (USAC) Q2 2026 Earnings Call Transcript
- 2026-08-04 USA Compression Partners Reports Second-Quarter 2026 Results DALLAS--(BUSINESS WIRE)--USA Compression Partners, LP (NYSE: USAC) (“USA Compression” or the “Partnership”) announced today its financial and operating results for second-quarter 2026. Financial Highlights Total revenues of $342.1 million for second-quarter 2026, compared to $250.1 million for second-quarter 2025. Net income was $45.7 million for second-quarter 2026, compared to $28.6 million for second-quarter 2025. Net cash provided by operating activities was $145.7 million for second-quarte.
- 2026-07-29 Boomers Are Buying 5 Quality High-Yield Stocks at Big Discounts Hand Over Fist While many Baby Boomers have enjoyed a long bull market over the past 35 years, there is a point when income becomes more critical than stock appreciation.